ATE140028T1 - Rekombinantes dns-molekül zur expression von fv- fragmenten eines antikörpers - Google Patents

Rekombinantes dns-molekül zur expression von fv- fragmenten eines antikörpers

Info

Publication number
ATE140028T1
ATE140028T1 AT92202294T AT92202294T ATE140028T1 AT E140028 T1 ATE140028 T1 AT E140028T1 AT 92202294 T AT92202294 T AT 92202294T AT 92202294 T AT92202294 T AT 92202294T AT E140028 T1 ATE140028 T1 AT E140028T1
Authority
AT
Austria
Prior art keywords
antibody
interferon
recombinant dna
expressing
host
Prior art date
Application number
AT92202294T
Other languages
English (en)
Inventor
Alfons Jozef Denis Ali Billiau
Guido Frans Valentius Froyen
Original Assignee
Stichting Rega V Z W
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stichting Rega V Z W filed Critical Stichting Rega V Z W
Application granted granted Critical
Publication of ATE140028T1 publication Critical patent/ATE140028T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/249—Interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
AT92202294T 1991-07-23 1992-07-23 Rekombinantes dns-molekül zur expression von fv- fragmenten eines antikörpers ATE140028T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL9101290A NL9101290A (nl) 1991-07-23 1991-07-23 Recombinant dna-molecuul voor de expressie van een fv-fragment van een antilichaam.

Publications (1)

Publication Number Publication Date
ATE140028T1 true ATE140028T1 (de) 1996-07-15

Family

ID=19859551

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92202294T ATE140028T1 (de) 1991-07-23 1992-07-23 Rekombinantes dns-molekül zur expression von fv- fragmenten eines antikörpers

Country Status (5)

Country Link
EP (1) EP0528469B1 (de)
AT (1) ATE140028T1 (de)
DE (1) DE69211922T2 (de)
ES (1) ES2089367T3 (de)
NL (1) NL9101290A (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6010861A (en) * 1994-08-03 2000-01-04 Dgi Biotechnologies, Llc Target specific screens and their use for discovering small organic molecular pharmacophores
US20020025316A1 (en) 1995-08-18 2002-02-28 Ferguson Mark Williams James Pharmaceutical composition containing inhibitors of interferon-gamma
GB2304342A (en) * 1995-08-18 1997-03-19 Univ Manchester Pharmaceutical comprising either an inhibitor or a stimulator of interferon gamma
WO2004034988A2 (en) 2002-10-16 2004-04-29 Amgen Inc. Human anti-ifn-ϝ neutralizing antibodies as selective ifn-ϝ pathway inhibitors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI903489A7 (fi) * 1988-11-11 1990-07-10 Medical Res Council Yhden osan sisältävät ligandit, näitä ligandeja sisältävät reseptorit, menetelmiä niiden valmistamiseksi sekä ligandien ja reseptorien käytt ö

Also Published As

Publication number Publication date
NL9101290A (nl) 1993-02-16
ES2089367T3 (es) 1996-10-01
DE69211922T2 (de) 1997-02-27
EP0528469B1 (de) 1996-07-03
EP0528469A1 (de) 1993-02-24
DE69211922D1 (de) 1996-08-08

Similar Documents

Publication Publication Date Title
DK383189D0 (da) Fremgangsmaade til mikrobiologisk fremstilling af humant serum albumin og lignende heterologe proteiner ved hjaelp af gaer
HK49285A (en) Interferons and process for their preparation
FI965220A0 (fi) Ei-toksinen, ei-toksigeeninen, ei-patogeeninen Fusarium-ilmentämissysteemi ja siinä käytettävät promootterit ja terminaattorit
ATE253633T1 (de) Cystic fibrosis gen
ES2092995T3 (es) Metodo para producir celulas conteniendo un adn extraño establemente integrado con un numero alto de copia, las celulas producidas por este metodo y el uso de estas celulas para producir el polipeptido codificado por el adn extraño.
ES2165881T3 (es) Constructo de adn que codifica el peptido señal yap3.
ZA91134B (en) New proteins produced by human lymphocytes,dna sequence encoding these proteins and their pharmaceutical and biological uses
EP0048970A3 (de) Polypeptide, Verfahren zu ihrer mikrobischen Herstellung, Zwischenprodukte dafür und diese enthaltende Zusammensetzungen
EP0713495A4 (de) Methoden zur erhöhung der biologischen aktivität von chemokinen
ATE179459T1 (de) Verfahren zur typisierung von hcv-isolaten
AU1515992A (en) Improvement of the yield when disulfide-bonded proteins are secreted
AU1094892A (en) Improved activation of recombinant proteins
ATE263836T1 (de) Chimere proteine, welche borrelia polypeptide beinhalten, verwendungen dafür
PT80901A (de) Neue genetische sequenzen die durch sie codierten interferon-peptide von typ i und diese sie produzierende organismen
ATE248918T1 (de) Rekombinante dnase b aus streptococcus pyogenes
DE58907690D1 (de) Verfahren zur Expression eines rekombinanten Gens.
DE69635639D1 (de) Interleukin-12-beta-Rezeptoren mit niedriger Bindungsaffinität
DE69211922D1 (de) Rekombinantes DNS-Molekül zur Expression von FV-Fragmenten eines Antikörpers
DK0434605T3 (da) Ny fremgangsmåde til fremstilling af ikke-fusioneret protein i E.coli
EP1203775A3 (de) Chemoattraktion-auslösender Faktor aus Lymphozyten und dessen Verwendung
WO1999003993A3 (en) Suppressors of cytokine signaling; related reagents
DE69013471D1 (de) Methode zur Stabilisierung von rekombinanten Hepatitis-B-Virus-Oberflächenproteinen aus Hefe.
ATE142263T1 (de) Verfahren zur herstellung von fremdproteinen in streptomyceten
AU4469889A (en) Interferon-gamma binding proteins
KR900003367A (ko) 유전자 발현 조절인자

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee